Axogen, Inc. (AXGN) stock
AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30142% above fair value
$55.37−0.01 (-0.02%)
Close on Nov 17, 2026Market cap $3.31BP/E –Yield –
Axogen price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Axogen's price to book ratio was 12.3× on Nov 11, 2026, against 10.9× a year earlier. Over the last 5 years it ranged from 1.7× to 15.8×, with a median of 4.7×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 12.3× | −0.2 |
| 2025 | Dec 31, 2025 | 12.5× | +5.2 |
| 2024 | Dec 31, 2024 | 7.3× | +4.3 |
| 2023 | Dec 29, 2023 | 3.0× | −1.2 |
| 2022 | Dec 30, 2022 | 4.2× | +0.8 |
| 2021 | Dec 31, 2021 | 3.4× | −2.5 |
| 2020 | Dec 31, 2020 | 5.9× | +0.7 |
| 2019 | Dec 31, 2019 | 5.2× | −0.1 |
| 2018 | Dec 31, 2018 | 5.3× | −84.3 |
| 2017 | Dec 29, 2017 | 89.6× | −156.8 |
| 2016 | Dec 30, 2016 | 246.3× | +233.0 |
| 2015 | Dec 31, 2015 | 13.4× | −309.0 |
| 2014 | Apr 30, 2014 | 322.3× | +303.4 |
| 2013 | Dec 31, 2013 | 18.9× | −5.9 |
| 2012 | Dec 31, 2012 | 24.8× | +21.1 |
| 2011 | Dec 30, 2011 | 3.7× | – |
See a number that looks wrong?